OCTOBER 05, 2014 12:52 AM CET SEARCH T&C'S DISCLAIMER PRIVACY POLICY IMPRINT RSS ©2014 EVOTEC HOME CONTACT US CAREERS DOWNLOADS LOADING... ABOUT US OUR SERVICES PRODUCTS & ALLIANCES SCIENCE POOL INVESTORS TOP STORY Evotec receives milestone as part of its multi-target alliance with Bayer HealthCare Hamburg, Germany - 30 September 2014: Evotec AG announced today that its multi-target collaboration with Bayer HealthCare ("Bayer") has reached an important milestone for the transition - READ MORE Evotec and its partners awarded public grants to develop new drug candidates to treat multiple sclerosis Hamburg, Germany - 24 September 2014: Evotec AG announced today that it has entered into three novel research projects for the treatment of Multiple Sclerosis ("MS") supported by research - READ MORE Evotec takes legal steps against Andromeda Biotech, Ltd. Hamburg, Germany - 18 September 2014: Evotec AG announced today after careful evaluation that it will take legal steps against Israel-based Andromeda Biotech, Ltd. to recover all Evotec claims and potential damages that result from recent incidents in relation to DiaPep277®. - READ MORE Request Information Services and Partnering Opportunities Investor Relations/Public Relations Loading weather report... EVENTS OCT 07, 2014 - The 13th Annual BIO Investor Forum - MORE EVENTS OCT 16, 2014 - 6th Annual Healthcare Investor Conference - MORE EVENTS Company Presentation September Building integrated and high-value drug discovery alliances 2014-09_Evotec_Company presentation_September OCTOBER 05, 2014 12:52 AM CET SEARCH T&C'S DISCLAIMER PRIVACY POLICY IMPRINT RSS ©2014 EVOTEC